GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amarantus Bioscience Holdings Inc (OTCPK:AMBS) » Definitions » PB Ratio

Amarantus Bioscience Holdings (Amarantus Bioscience Holdings) PB Ratio : (As of May. 27, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Amarantus Bioscience Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-27), Amarantus Bioscience Holdings's share price is $0.0001. Amarantus Bioscience Holdings's Book Value per Share for the quarter that ended in Dec. 2015 was $-0.82. Hence, Amarantus Bioscience Holdings's PB Ratio of today is .

The historical rank and industry rank for Amarantus Bioscience Holdings's PB Ratio or its related term are showing as below:

AMBS's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.525
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Amarantus Bioscience Holdings PB Ratio Historical Data

The historical data trend for Amarantus Bioscience Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amarantus Bioscience Holdings PB Ratio Chart

Amarantus Bioscience Holdings Annual Data
Trend Oct08 Oct09 Oct10 Dec11 Dec12 Dec13 Dec14 Dec15
PB Ratio
Get a 7-Day Free Trial - - - - -

Amarantus Bioscience Holdings Semi-Annual Data
Oct08 Oct09 Oct10 Dec11 Dec12 Dec13 Dec14 Dec15
PB Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of Amarantus Bioscience Holdings's PB Ratio

For the Biotechnology subindustry, Amarantus Bioscience Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amarantus Bioscience Holdings's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amarantus Bioscience Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Amarantus Bioscience Holdings's PB Ratio falls into.



Amarantus Bioscience Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Amarantus Bioscience Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2015)
=0.0001/-0.824
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Amarantus Bioscience Holdings  (OTCPK:AMBS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Amarantus Bioscience Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Amarantus Bioscience Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amarantus Bioscience Holdings (Amarantus Bioscience Holdings) Business Description

Traded in Other Exchanges
N/A
Address
45 Wall Street, Suite 920, New York, NY, USA, 10005
Amarantus Bioscience Holdings Inc is a biopharmaceutical company. It is focused on developing therapeutic products for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company's prime therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia. The group's diagnostics division is dedicated to the development and commercialization of neurology diagnostic products. Its diagnostic product, LymPro Test is a blood-based assay to diagnose Alzheimer's disease.
Executives
Flanigan Conn other: Former Director 1601 BLAKE STREET, SUITE 310, DENVER CO 80202
Robert Edward Farrell officer: CFO BIOVEST INTERNATIONAL, INC., 300 S HYDE PARK AVENUE, SUITE 210, TAMPA FL 33606
Joseph Rubinfeld director C/O SUPERGEN INC, 4140 DUBLIN BLVD STE 200, DUBLIN CA 94568